UBS Group’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
UBS Group's ALAB Position: Q3 2026 in Review
UBS Group reduced its Astera Labs (ALAB) stake by 20% in Q3 2026, selling an estimated $50.6M and leaving 644,794 shares worth $230M. The position accounts for 0.03% of the portfolio, ranked #586.
UBS Group first reported a position in ALAB in Q1 2024 and has held it in 11 quarters since. The position peaked at $387M in Q2 2026. 1,006 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.
- UBS Group held 644,794 shares of Astera Labs worth $230M as of Q3 2026.
- UBS Group sold 157,230 Astera Labs shares in Q3 2026, an estimated $50.6M.
- Astera Labs made up 0.03% of UBS Group's portfolio in Q3 2026, its #586 holding.
- UBS Group first reported a position in Astera Labs in Q1 2024 and has held it in 11 quarters since.
- UBS Group's Astera Labs position peaked at $387M in Q2 2026.
- 1,006 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.